We are live on ! Find out more
SGA

Sector Gamma AS Portfolio holdings

AUM $423M
1-Year Est. Return 17.56%
This Fund
S&P 500
This Quarter Est. Return
+2.5%
1 Year Est. Return
+17.56%
3 Year Est. Return
+28.73%
5 Year Est. Return
+52.48%
10 Year Est. Return
+238.19%
AUM
$555M
AUM Growth
-$40.1M
Cap. Flow
-$46.8M
Cap. Flow %
-8.43%
Top 10 Hldgs %
62.94%
Holding
41
New
5
Increased
14
Reduced
11
Closed
11

Top Buys

Rank Stock Value
1
CAH icon
Cardinal Health
CAH
+$15.5M
2
SHPG
Shire pic
SHPG
+$13.5M
3
IONS icon
Ionis Pharmaceuticals
IONS
+$10.7M
4
UHS icon
Universal Health Services
UHS
+$10.3M
5
MRK icon
Merck
MRK
+$9.44M

Top Sells

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$21M
2
GILD icon
Gilead Sciences
GILD
+$20.2M
3
CI icon
Cigna
CI
+$14.9M
4
MCK icon
McKesson
MCK
+$10.5M
5
PRGO icon
Perrigo
PRGO
+$9.75M

Sector Composition

Rank Sector Weight
1 Healthcare 98.65%
2 Industrials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ABT icon
1
Abbott
ABT
$175B
$66.3M 11.94%
1,105,642
+25,800
+2% +$1.55M
BSX icon
2
Boston Scientific
BSX
$65.4B
$47.6M 8.57%
1,741,380
+40,500
+2% +$1.1M
BAX icon
3
Baxter International
BAX
$11.7B
$46.5M 8.39%
715,438
+21,000
+3% +$1.42M
MRK icon
4
Merck
MRK
$315B
$39.5M 7.12%
760,010
+174,702
+30% +$9.44M
RVTY icon
5
Revvity
RVTY
$12.3B
$28.6M 5.16%
378,206
-62,602
-14% -$4.83M
AZN icon
6
AstraZeneca
AZN
$262B
$28.2M 5.08%
403,018
-45,368
-10% -$3.14M
SHPG
7
DELISTED
Shire pic
SHPG
$24.6M 4.44%
164,975
+97,900
+146% +$13.5M
BIO icon
8
Bio-Rad Laboratories Class A
BIO
$8.15B
$23.6M 4.25%
94,240
-800
-0.8% -$204K
BMY icon
9
Bristol-Myers Squibb
BMY
$124B
$22.9M 4.13%
362,006
-23,000
-6% -$1.48M
IART icon
10
Integra LifeSciences
IART
$1.5B
$21.4M 3.86%
386,966
-119,664
-24% -$6.27M
LLY icon
11
Eli Lilly
LLY
$1.05T
$19.5M 3.52%
252,514
+99,100
+65% +$7.98M
NUVA
12
DELISTED
NuVasive, Inc.
NUVA
$19.4M 3.5%
371,997
+111,797
+43% +$5.67M
ELV icon
13
Elevance Health
ELV
$80.9B
$18.9M 3.4%
85,910
-35,400
-29% -$8.32M
IRWD icon
14
Ironwood Pharmaceuticals
IRWD
$635M
$17.3M 3.12%
1,338,635
-80,497
-6% -$1M
CAH icon
15
Cardinal Health
CAH
$53.5B
$14.2M 2.56%
+226,263
New +$15.5M
LH icon
16
Labcorp
LH
$23.2B
$13.7M 2.46%
98,242
+5,122
+6% +$752K
THC icon
17
Tenet Healthcare
THC
$16.8B
$12.9M 2.33%
534,021
+68,400
+15% +$1.36M
IONS icon
18
Ionis Pharmaceuticals
IONS
$8.99B
$12.1M 2.17%
273,500
+211,400
+340% +$10.7M
PRGO icon
19
Perrigo
PRGO
$1.48B
$11.5M 2.07%
137,840
-111,700
-45% -$9.75M
AGN
20
DELISTED
Allergan plc
AGN
$10.8M 1.95%
64,300
+1,700
+3% +$285K
UHS icon
21
Universal Health Services
UHS
$9.15B
$10.3M 1.86%
+86,973
New +$10.3M
GILD icon
22
Gilead Sciences
GILD
$167B
$7.8M 1.41%
103,500
-254,390
-71% -$20.2M
LXRX icon
23
Lexicon Pharmaceuticals
LXRX
$1.06B
$7.32M 1.32%
854,592
+17,400
+2% +$161K
PDCO
24
DELISTED
Patterson Companies, Inc.
PDCO
$6.94M 1.25%
312,232
+9,100
+3% +$283K
CLVS
25
DELISTED
Clovis Oncology, Inc.
CLVS
$6.54M 1.18%
123,892
-27,100
-18% -$1.58M
1
2

Similar funds

AFWM
AMJ Financial Wealth Management Leesburg, Virginia $424M AUM 37.24% 1-Year Est. Return
MP
McDonald Partners Cleveland, Ohio $424M AUM 29.07% 1-Year Est. Return
DS
Dalal Street West Lake Hills, Texas $423M AUM 115.19% 1-Year Est. Return
RS
Retirement Solution Redmond, Washington $423M AUM 16.83% 1-Year Est. Return
DF
Dunhill Financial London, United Kingdom $424M AUM 16.79% 1-Year Est. Return
OGM
OnyxPoint Global Management New York $424M AUM 84.95% 1-Year Est. Return
CPIM
Cypress Point Investment Management Mill Valley, California $424M AUM
MPPLM
Midwest Professional Planners Ltd (MPPL) Wausau, Wisconsin $425M AUM 28.89% 1-Year Est. Return

Sector Gamma AS's Q1 2018 Portfolio in Review

As of Q1 2018, Sector Gamma AS held 41 positions worth $555M, down 6.7% from $595M the previous quarter. Its ten largest holdings account for 63% of the portfolio.

Sector Gamma AS withdrew a net $46.8M in Q1 2018, closing 11 positions and reducing 11 holdings. Its most notable exit was Biogen, an estimated $21M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 99% of assets, up from 98% a quarter earlier, followed by Industrials.

Against the trend, Sector Gamma AS opened a new position in Cardinal Health worth $14.2M.

  • Sector Gamma AS's largest Q1 2018 buy was Cardinal Health: 226,263 shares worth $14.2M.
  • Sector Gamma AS added most to Shire pic in Q1 2018, an estimated $13.5M increase.
  • Sector Gamma AS's biggest Q1 2018 reduction was Gilead Sciences, cutting an estimated $20.2M.
  • Sector Gamma AS fully exited Biogen in Q1 2018, selling an estimated $21M.
  • Sector Gamma AS's ten largest holdings make up 63% of its $555M portfolio in Q1 2018.
  • Sector Gamma AS opened 5 new positions and closed 11 in Q1 2018.
  • Sector Gamma AS's portfolio value fell 6.7% quarter-over-quarter to $555M.

Based on Sector Gamma AS's 13F filing for Q1 2018, filed 9 May 2018.